Legal Issues
Conor Medsystems announces decision from U.K. Court of Appeal
Published in Cardiovascular Device Liability Week, February 18th, 2007
The patent is exclusively licensed to Boston Scientific Corporation for use in the field of coronary stents.
On February 18, 2005, Conor Medsystems initiated proceedings against Angiotech and the University of British Columbia in the High Court of Justice in the United Kingdom requesting that the court invalidate EP 0 706 376 B1 based on the grounds that all claims of the patent either lack novelty or are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Legal Issues
Conor Medsystems comments on Netherlands court decision on Angiotech patent - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm study findings recently were reported by researchers at Baylor University, Department of Internal Medicine - Abdominal Aortic Aneurysm Risk Factors
Researchers from Bezm-I Alem Vakif Gureba Hospital report recent findings in abdominal aortic aneurysm risk factors - Acidosis Cell Biology
Scientists at Oxford University discuss research in acidosis cell biology - Alcoholism Therapy
Data on alcoholism therapy detailed by investigators at Scripps Research Institute - Angiology
ProRhythm initiates U.S. pivotal trial for HIFU ablation system - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
